Form 8-K - Current report:
SEC Accession No. 0001079973-12-000973
Filing Date
2012-12-13
Accepted
2012-12-12 19:06:42
Documents
3
Period of Report
2012-12-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K appy_8k.htm 8-K 39706
2 EXHIBIT 3.1 ex3x1.htm EX-3.1 45055
3 EXHIBIT 10.1 ex10x1.htm EX-10.1 7765
  Complete submission text file 0001079973-12-000973.txt   93988
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33675 | Film No.: 121260305
SIC: 2835 In Vitro & In Vivo Diagnostic Substances